• A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

    9 days ago - By Xconomy

    Cyrus Biotechnology and the Broad Institute of MIT and Harvard have teamed up to make gene editing with the CRISPR-Cas9 technology safer. The multi-target collaboration, specific details of which are not being disclosed, aims to address longstanding concerns surrounding gene editing: some patients might be predisposed to an immune reaction to the DNA-cutting enzyme Cas9. That response could make the technology ineffective, or worse, harm the patient. Recent research has validated these concerns , revealing evidence of immunity against Cas9 enzymes in humans. Taking aim at what CEO Lucas...
    Read more ...